Skip to content

Author

Harvey A. Risch

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#protein folding Open access Sep 2026

Proteolytic Targets and Clinical Benefits of Oral Nattokinase: Spike Protein and Amyloid Degradation, Fibrinolysis, and Cardiovascular Risk Reduction

Abstract Nattokinase (NK) is an orally administered subtilisin-family serine protease with reported activity across multiple interconnected proteolytic and cardiovascular targets, including degradation of SARS-CoV-2 spike protein, fibrinaloid amyloid microclots, fibrin clots, and classical amyloid substrates; enhanceme...

Nicolas Hulscher, Harvey A. Risch, James A. Thorp et al. · 0 citations
#protein folding Open access Sep 2026

Proteolytic Targets and Clinical Benefits of Oral Nattokinase: Spike Protein and Amyloid Degradation, Fibrinolysis, and Cardiovascular Risk Reduction

Abstract Nattokinase (NK) is an orally administered subtilisin-family serine protease with reported activity across multiple interconnected proteolytic and cardiovascular targets, including degradation of SARS-CoV-2 spike protein, fibrinaloid amyloid microclots, fibrin clots, and classical amyloid substrates; enhanceme...

Nicolas Hulscher, Harvey A. Risch, James A. Thorp et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.